Last edition
News about "Qnovia, Inc."
Qnovia Secures Global License for Novel Antimicrobial Peptide to Combat Drug-Resistant Infections
Qnovia has obtained worldwide exclusive rights from the University of Virginia to develop and commercialise the D8 antimicrobial peptide, a novel therapy designed to target multidrug-resistant bacterial infections through a unique mechanism.
Qnovia, Inc. | 31/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members